Loading market data...
Latest Top News
Show more
RPG Life Sciences Delivers Strong Q4, Declares 300% Dividend
RPG Life Sciences Limited reported a robust Q4 FY26 performance with consolidated revenue of Rs 1.77 billion and profit of Rs 299 million. The company announced a final dividend of Rs 24 per share (300%) for FY25-26, underscoring its strong operational momentum and market-beating growth across key segments.
Stay Ahead – Explore Now! India’s Digital Public Infrastructure Projected To Contribute 4% Of GDP By 2030






